Demidova TY - Search Results

1

[Management of patients with insomnia and polymorbidity: expert consensus].

Poluektov MG, Akarachkova ES, Dovgan EV, Kotova OV, Demidova TY, Klimenko AA, Kokorin VA, Ostroumova OD, Ostroumova TM. Poluektov MG, et al. Among authors: demidova ty. Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(5. Vyp. 2):49-57. doi: 10.17116/jnevro202312305249. Zh Nevrol Psikhiatr Im S S Korsakova. 2023. PMID: 37275998 Russian.

2

[Management of patients with insomnia and polymorbidity. A draft of the clinical guidelines].

Poluektov MG, Akarachkova ES, Dovgan EV, Kotova OV, Demidova TY, Klimenko AA, Kokorin VA, Ostroumova OD, Ostroumova TM. Poluektov MG, et al. Among authors: demidova ty. Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124(5. Vyp. 2):39-52. doi: 10.17116/jnevro202412405239. Zh Nevrol Psikhiatr Im S S Korsakova. 2024. PMID: 38934665 Russian.

3

[Changes in the synthesis of short-chain fatty acids under the influence of various factors in healthy people and patients with type 2 diabetes mellitus].

Demidova TY, Teplova AS. Demidova TY, et al. Vopr Pitan. 2024;93(1):33-43. doi: 10.33029/0042-8833-2024-93-1-33-43. Epub 2023 Dec 26. Vopr Pitan. 2024. PMID: 38555608 Russian.

4

[Non-alcoholic fatty liver disease: aspects of management of a comorbid patient. A review].

Demidova TY, Ushanova FO. Demidova TY, et al. Ter Arkh. 2023 Nov 23;95(10):888-895. doi: 10.26442/00403660.2023.10.202435. Ter Arkh. 2023. PMID: 38159023 Review. Russian.

5

[Advantages of glucagon-like peptide-1 receptor agonists in the treatment of patients with type 2 diabetes mellitus: A review].

Demidova TY, Titova VV, Izmaylova MY. Demidova TY, et al. Ter Arkh. 2023 Nov 23;95(10):876-880. doi: 10.26442/00403660.2023.10.202425. Ter Arkh. 2023. PMID: 38159021 Review. Russian.

6

[Retrospective analysis of clinical outcomes of patients with COVID-19 depending on receiving antihypertensive, lipid-lowering and antihypertensive therapy].

Demidova TY, Lobanova KG, Perekhodov SN, Antsiferov MB, Oynotkinova OS. Demidova TY, et al. Ter Arkh. 2021 Oct 15;93(10):1193-1202. doi: 10.26442/00403660.2021.10.201072. Ter Arkh. 2021. PMID: 36286821 Russian.

7

[The use of drug based on technologically processed antibodies to endocannabinoid receptor type 1 in the treatment of obesity in adults: results of a multicenter double blind placebo controlled randomized clinical trial].

Demidova TY, Krasil'nikova EI, Vorob'ev SV, Morugova TV, Adasheva TV. Demidova TY, et al. Ter Arkh. 2021 Aug 15;93(8):904-915. doi: 10.26442/00403660.2021.08.200898. Ter Arkh. 2021. PMID: 36286885 Clinical Trial. Russian.

8

[Insulin therapy is a personalized approach to glycemic management in diabetes].

Demidova TY, Titova VV. Demidova TY, et al. Ter Arkh. 2020 Dec 15;92(12):201-206. doi: 10.26442/00403660.2020.12.200449. Ter Arkh. 2020. PMID: 33720595 Russian.

9

[Gut microbiota is a factor of risk for obesity and type 2 diabetes].

Demidova TY, Lobanova KG, Oinotkinova OS. Demidova TY, et al. Ter Arkh. 2020 Nov 24;92(10):97-104. doi: 10.26442/00403660.2020.10.000778. Ter Arkh. 2020. PMID: 33346486 Russian.

10

[Changes in the intestinal microbiota as a risk factor for dyslipidemia, atherosclerosis and the role of probiotics in their prevention].

Oynotkinova OS, Nikonov EL, Demidova TY, Baranov AP, Kryukov EV, Dedov EI, Karavashkina EA. Oynotkinova OS, et al. Among authors: demidova ty. Ter Arkh. 2020 Oct 14;92(9):94-101. doi: 10.26442/00403660.2020.09.000784. Ter Arkh. 2020. PMID: 33346437 Russian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters